On the contrary, there are several canonical pathways being activated in the stromal cell component of GDF15-KD tumor after cisplatin treatment compared to the GDF15-NT control such as the RhoGDI signaling pathway and the acute phase response signaling pathway. Here, ARHGDIA is linked to neoplasm.